Longeveron LLC (LGVN)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 23.33M
P/E Ratio
0.00
Revenue (TTM)
$ 2.39M
Volume
0
52W High
$ 6.40
52W Low
$ 0.77
Dividend Yield
0.00%
Beta
0.38
Technicals
50-Day MA
1.5545
200-Day MA
1.9514
52 Week High
6.4
52 Week Low
0.7707
About LGVN
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States.
Employees
25
Headquarters
Miami, FL
CEO
Dr. Joshua Michael Hare FACC, M.D.
Latest News
Analysts Expect Breakeven For Longeveron Inc. (NASDAQ:LGVN) Before Long - Yahoo Finance
2025-03-02 • Google News
Peeling Back The Layers: Exploring Longeveron Through Analyst Insights - Fidelity
2024-11-04 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg